on VALNEVA (EPA:VLA)
Valneva to Announce First Half 2026 Financial Results
Valneva SE, a company specializing in vaccines, will publish its financial results for the first half of 2026 on August 13. The company plans a live webcast at 3 p.m. CET to discuss these results and offer a business update. The webcast will be accessible on Valneva's official website, with an archived version available post-event.
Valneva focuses on developing vaccines for infectious diseases with unmet medical needs. Their pipeline includes partnerships for significant vaccine candidates, such as the Lyme disease vaccine with Pfizer. Other advanced developments include vaccines targeting Shigella and various global health threats.
The announcement contains forward-looking statements about Valneva's business development and market approvals, emphasizing underlying uncertainties. These factors could affect the company’s future performance and results, despite current expectations.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALNEVA news